Evergreen Capital Management LLC Has $9.07 Million Stock Position in Chemed Corporation $CHE

Evergreen Capital Management LLC raised its holdings in shares of Chemed Corporation (NYSE:CHE) by 95.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,262 shares of the company’s stock after buying an additional 9,913 shares during the quarter. Evergreen Capital Management LLC owned about 0.14% of Chemed worth $9,072,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Creekmur Asset Management LLC acquired a new position in Chemed during the 2nd quarter valued at $28,000. First Horizon Corp bought a new position in shares of Chemed during the 3rd quarter worth about $31,000. Parkside Financial Bank & Trust raised its position in shares of Chemed by 86.3% during the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after buying an additional 44 shares during the last quarter. HM Payson & Co. lifted its stake in shares of Chemed by 35.5% in the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after buying an additional 27 shares during the period. Finally, Geneos Wealth Management Inc. grew its position in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Price Performance

Shares of CHE stock opened at $452.40 on Friday. The stock’s fifty day simple moving average is $435.69 and its 200 day simple moving average is $444.32. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60. The firm has a market cap of $6.41 billion, a price-to-earnings ratio of 23.92, a P/E/G ratio of 2.24 and a beta of 0.44.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). The firm had revenue of $624.90 million for the quarter, compared to the consensus estimate of $626.04 million. Chemed had a return on equity of 25.89% and a net margin of 11.02%.The company’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.64 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, research analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, November 17th. Chemed’s payout ratio is 12.69%.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the transaction, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. This trade represents a 2.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.29% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have commented on the company. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Finally, Royal Bank Of Canada decreased their price target on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $574.25.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.